Precision Neuroscience acquires MEMS manufacturing facility in Texas
Precision BioMEMS acquired the 22,000 ft2 facility that includes an ISO Class-5 clean room for manufacturing, an ISO…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Oct 23
Precision BioMEMS acquired the 22,000 ft2 facility that includes an ISO Class-5 clean room for manufacturing, an ISO…
06 Oct 23
BENEFIT-02 is a multicentre, randomised, single-blind, feasibility study that evaluated the effectiveness of Resonance multiphase stimulation used in…
28 Sep 23
Together with the ARC-IM Stimulator, patients also received a wireless brain-computer interface (BCI), which enables the delivery of…
22 Sep 23
The study of the micro-neuromodulation system is slated to take place at the Cleveland Clinic, a nonprofit academic…
21 Sep 23
The clinical study, dubbed OrcHESTRAS, is a prospectively enrolled study that will further characterise the long-term economic and…
20 Sep 23
Established in 2006, Relievant is a medical technology company that developed and commercialised the Intracept Intraosseous Nerve Ablation…
20 Sep 23
The American neurotechnology company has secured approval from the reviewing independent institutional review board and its first hospital…
20 Sep 23
The FDA’s BDD covers the graphene-neural platform as an adjunctive therapy for Parkinson’s disease by combining machine learning…
19 Sep 23
The study, published in the preprint server medrxiv, showed that the implant can offer safe and effective brain…
14 Sep 23
A world first, CERVAI on track for commercialization in Q4-2023